Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Nov;5(22):452.
doi: 10.21037/atm.2017.11.35.

Does animal model on ventilator-associated pneumonia reflect physiopathology of sepsis mechanisms in humans?

Affiliations
Review

Does animal model on ventilator-associated pneumonia reflect physiopathology of sepsis mechanisms in humans?

Laura Pulido et al. Ann Transl Med. 2017 Nov.

Abstract

Ventilator-associated pneumonia (VAP) is the leading cause of death in critically ill patients in intensive care units. In the last 20 years, different animal models have been a valuable tool for the study of pathophysiology and phenotypic characteristics of different lung infections observed in humans, becoming an essential link between ''in vitro'' testing and clinical studies. Different animal models have been used to study the mechanism of a deregulated inflammatory response and host tissue damage of sepsis in VAP, as well as different infection parameters such as clinical, physiological, microbiological and pathological facts in several large and small mammals. In addition, the dosage of inflammatory modulators and their consequences in local and systemic inflammation, or even the administration of antibiotics, have been evaluated with very interesting results. Although some bronchial inoculation ways do not resemble the common pathophysiologic mechanisms, the experimental model of VAP induced by the inoculation of high concentrations of pathogens in mechanically ventilated animals is useful for studying the local and systemic responses of sepsis in VAP and it reproduces biological mechanisms such as acute lung injury, distress response, cardiac events and immune modulation comparable with clinical studies.

Keywords: Animal model; antimicrobial therapy; inflammatory markers; sepsis mechanisms; ventilator-associated pneumonia (VAP).

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Temperature, PaO2/FiO2, airway pressures and compliance variations in piglets. (A) (a) After inoculation the temperature rose steeply, being 36.6±1.0 °C, at baseline and rising to 39.4±1.4 °C at 24 hours (*), P=0.0002 and 38.1±1.8 °C at 48 hours (*), P=0.021. (b) body temperature tended to be higher in piglets not receiving ABT, beginning 24 hours after inoculation. This difference became significant at the last measurement before death or sacrifice (*) P=0.018. (B) PaO2/FiO2 decreased over time, becoming significant 24 hours after inoculation, basal =386 and at 24 hours =242 mmHg (*), P=0.034. (C) Peak and plateau pressures and compliance in the overall population at the different time points from the time of inoculation to the time of sacrifice. A continuous increase in airway pressures was obvious from the beginning of the experiment achieving significance at 2 hours, P=0.003 for peak (*) and P=0.007 for plateau (§) pressures. Static compliance reduction became significant at 72 hours (ǂ), P=0.009. These changes may be attributed to pneumonia and to acute lung injury. According with Luna et al. (25).
Figure 2
Figure 2
Confluent pneumonia. Micro-photograph showing alveolar spaces with polymorphonuclear leukocytes infiltration. It also shows the alveolar epithelium covered by hyaline membranes. Hematoxylin-eosin 250×. According with Luna et al. (25).
Figure 3
Figure 3
Abscess pneumonia. Consolidation; infiltration of polymorphonuclear leukocytes, fibrinous exudates, and cellular necrosis with disruption of cellular architecture. Hematoxylin-eosin 250×. According with Luna et al. (25).

Similar articles

Cited by

References

    1. American Thoracic Society. Infectious Diseases Society of America Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia. Am J Respir Crit Care Med 2005;171:388-416. 10.1164/rccm.200405-644ST - DOI - PubMed
    1. Torres A, Niederman MS, Chastre J, et al. International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociación Latinoamericana del Tórax (ALAT). Eur Respir J 2017;50. pii: 1700582. 10.1183/13993003.00582-2017 - DOI - PubMed
    1. Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016;315:801-10. 10.1001/jama.2016.0287 - DOI - PMC - PubMed
    1. Wichterman KA, Baue AE, Chaudry IH. Sepsis and septic shock: a review of laboratory models and a proposal. J Surg Res 1980;29:189-201. 10.1016/0022-4804(80)90037-2 - DOI - PubMed
    1. Marquette CH, Wermert D, Wallet F, et al. Characterization of an animal model of ventilator-acquired pneumonia. Chest 1999;115:200-9. 10.1378/chest.115.1.200 - DOI - PubMed

LinkOut - more resources